Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 GlaxoSmithKlineBayerAstraZenecaDechra PharmaceuticalsHutchison China MediTech
Price Information
Current PriceGBX 1,650.40€66.68GBX 8,660GBX 2,890GBX 442
52 Week RangeHoldN/AHoldHoldHold
Beat the Market™ Rank
Overall Score2.
Analysis Score3.
Community Score1.
Dividend Score2.
Ownership Score3.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationHoldN/AHoldHoldHold
Consensus Price TargetGBX 1,849.88N/AGBX 8,308.89GBX 2,931.25GBX 360
% Upside from Price Target12.09% upsideN/A-4.05% downside1.43% upside-18.55% downside
Trade Information
Market Cap£81.57 billion$65.51 billion£111.00 billion£3.12 billion£3.05 billion
Average Volume9,120,000N/A2,310,000282,45213,897
Sales & Book Value
Annual Revenue£35.18 billion$44.14 billion£25.25 billion£498.90 million£204.89 million
Price / Sales2.351.484.506.2614.90
CashflowGBX 99.08 per share€5.14 per shareGBX 319.94 per shareGBX 62.44 per shareGBX 33 per share
Price / Cash16.6612.9727.0746.2813.39
Book ValueGBX 263.10 per share€49.48 per shareGBX 821.50 per shareGBX 464.10 per shareGBX 43.20 per share
Price / Book0.061.350.110.060.10
Net IncomeN/AN/AN/AN/AN/A
EPSGBX 107€4.42GBX 115.70GBX 27.80GBX (16)
Trailing P/E Ratio15.4215.1074.85103.96N/A
Forward P/E Ratio
P/E GrowthN/A€2.17N/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutGBX 76€2.80GBX 218GBX 32N/A
Dividend Yield4.60%4.20%2.52%1.11%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio71.03%63.39%188.42%115.11%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio159.26%82.02%171.72%64.00%10.88%
Current Ratio0.87%1.48%0.75%0.94%2.80%
Quick Ratio0.54%0.97%0.56%0.55%2.63%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding5.02 billion982.42 million1.31 billion108.01 million690.57 million
Next Earnings Date7/29/2020 (Estimated)8/4/2020 (Estimated)7/30/2020 (Estimated)9/7/2020 (Estimated)7/30/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.